Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.

Senard O, Lafaurie M, Lesprit P, Nguyen Y, Lescure X, Therby A, Fihman V, Oubaya N, Lepeule R.

Eur J Clin Microbiol Infect Dis. 2019 Sep 11. doi: 10.1007/s10096-019-03701-0. [Epub ahead of print]

PMID:
31512147
2.

Are lipid-lowering drugs associated with a risk of cataract? A pharmacovigilance study.

Despas F, Rousseau V, Lafaurie M, De Canecaude C, Durrieu G, Bagheri H, Montastruc F, Montastruc JL.

Fundam Clin Pharmacol. 2019 Jun 28. doi: 10.1111/fcp.12496. [Epub ahead of print]

PMID:
31251421
3.

Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa.

Pilmis B, Petitjean G, Lesprit P, Lafaurie M, El Helali N, Le Monnier A; on behalf the ATB PK/PD study group.

Eur J Clin Microbiol Infect Dis. 2019 Aug;38(8):1457-1461. doi: 10.1007/s10096-019-03573-4. Epub 2019 May 9.

PMID:
31073653
4.

Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.

Ekstrand C, Linder M, Baricault B, Lafaurie M, Sailler L, Lapeyre-Mestre M, Kieler H, Moulis G, Bahmanyar S.

Thromb Res. 2019 Jun;178:124-131. doi: 10.1016/j.thromres.2019.04.016. Epub 2019 Apr 17.

5.

Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit.

Munier AL, Biard L, Legrand M, Rousseau C, Lafaurie M, Donay JL, Flicoteaux R, Mebazaa A, Mimoun M, Molina JM.

Int J Infect Dis. 2019 Feb;79:179-184. doi: 10.1016/j.ijid.2018.11.371. Epub 2018 Dec 6.

6.

Impact of an Acinetobacter baumannii outbreak on kidney events in a burn unit: A targeted machine learning analysis.

Vauchel T, Pirracchio R, Chaussard M, Lafaurie M, Rouveau M, Rousseau C, Benyamina M, Soussi S, Dépret F, Ferry A, Oueslati H, Chaouat M, Mimoun M, Jarlier V, Moreno N, Mebazaa A, Legrand M.

Am J Infect Control. 2019 Apr;47(4):435-438. doi: 10.1016/j.ajic.2018.09.010. Epub 2018 Nov 29.

PMID:
30503627
7.

Outcome and potentially modifiable risk factors for candidemia in critically ill burns patients: A matched cohort study.

Dudoignon E, Alanio A, Anstey J, Depret F, Coutrot M, Fratani A, Jully M, Cupaciu A, Chaussard M, Oueslati H, Ferry A, Benyamina M, de Tymowski C, Boccara D, Serror K, Chaouat M, Mimoun M, Lafaurie M, Denis B, Gits-Muselli M, Bretagne S, Mebazaa A, Legrand M, Soussi S; PRONOBURN group.

Mycoses. 2019 Mar;62(3):237-246. doi: 10.1111/myc.12872. Epub 2018 Dec 18.

PMID:
30478963
8.

Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital.

Lafaurie M, Pochard L, Lotiron C, Molinier L, Lapeyre-Mestre M, Jouanjus E.

Clin Drug Investig. 2018 Oct;38(10):977-982. doi: 10.1007/s40261-018-0679-4.

PMID:
30047105
9.

Outbreak of Invasive Wound Mucormycosis in a Burn Unit Due to Multiple Strains of Mucor circinelloides f. circinelloides Resolved by Whole-Genome Sequencing.

Garcia-Hermoso D, Criscuolo A, Lee SC, Legrand M, Chaouat M, Denis B, Lafaurie M, Rouveau M, Soler C, Schaal JV, Mimoun M, Mebazaa A, Heitman J, Dromer F, Brisse S, Bretagne S, Alanio A.

MBio. 2018 Apr 24;9(2). pii: e00573-18. doi: 10.1128/mBio.00573-18.

10.

Trichosporon inkin causing invasive infection with multiple skin abscesses in a renal transplant patient successfully treated with voriconazole.

Jannic A, Lafaurie M, Denis B, Hamane S, Metivier F, Rybojad M, Bouaziz JD, Bagot M, Jachiet M.

JAAD Case Rep. 2017 Dec 18;4(1):27-29. doi: 10.1016/j.jdcr.2017.10.008. eCollection 2018 Jan. No abstract available.

11.

Incidence, risk factors, and outcome of multidrug-resistant Acinetobacter baumannii acquisition during an outbreak in a burns unit.

Munier AL, Biard L, Rousseau C, Legrand M, Lafaurie M, Lomont A, Donay JL, de Beaugrenier E, Flicoteaux R, Mebazaa A, Mimoun M, Molina JM.

J Hosp Infect. 2017 Nov;97(3):226-233. doi: 10.1016/j.jhin.2017.07.020. Epub 2017 Jul 25.

PMID:
28751010
12.

HHV-6 reactivation as a cause of fever in autologous hematopoietic stem cell transplant recipients.

Colombier MA, Amorim S, Salmona M, Thieblemont C, Legoff J, Lafaurie M.

J Infect. 2017 Aug;75(2):155-159. doi: 10.1016/j.jinf.2017.05.011. Epub 2017 May 24.

PMID:
28551368
13.

[Febrile neutropenia: is ambulatory care possible]?

Lafaurie M.

Rev Prat. 2017 Feb;67(2):197-204. French.

PMID:
30512857
14.

Detection of Circulating Mucorales DNA in Critically Ill Burn Patients: Preliminary Report of a Screening Strategy for Early Diagnosis and Treatment.

Legrand M, Gits-Muselli M, Boutin L, Garcia-Hermoso D, Maurel V, Soussi S, Benyamina M, Ferry A, Chaussard M, Hamane S, Denis B, Touratier S, Guigue N, Fréalle E, Jeanne M, Shaal JV, Soler C, Mimoun M, Chaouat M, Lafaurie M, Mebazaa A, Bretagne S, Alanio A.

Clin Infect Dis. 2016 Nov 15;63(10):1312-1317. Epub 2016 Aug 17.

PMID:
27535951
15.

Not all β-lactams are equal regarding neurotoxicity.

Chaïbi K, Chaussard M, Soussi S, Lafaurie M, Legrand M.

Crit Care. 2016 Oct 27;20(1):350. No abstract available.

16.

Amoxicillin-clavulanic acid prescriptions at the Greater Paris University Hospitals (AP-HP).

Fusier I, Parent de Curzon O, Touratier S, Escaut L, Lafaurie M, Fournier S, Sinègre M, Lechat P, Vittecoq D; Anti-Infective Drug Committee (COMAI) of the public hospital system of the city of Paris (AP–HP).

Med Mal Infect. 2017 Feb;47(1):42-49. doi: 10.1016/j.medmal.2016.09.003. Epub 2016 Oct 17.

PMID:
27765474
17.

Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).

Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M.

Ann Intensive Care. 2016 Dec;6(1):90. doi: 10.1186/s13613-016-0189-6. Epub 2016 Sep 15. Review.

18.

[Cutaneous tuberculosis of the ear due to Mycobacterium bovis].

Lhote R, Raskine L, Gottlieb J, Mougari F, Lafaurie M, Vignon-Pennamen MD, Bagot M, Petit A, Cordoliani F.

Ann Dermatol Venereol. 2016 Oct;143(10):611-615. doi: 10.1016/j.annder.2016.05.009. Epub 2016 Jun 30. French.

PMID:
27375171
19.

Usefulness of daily surveillance blood cultures in allogeneic hematopoietic stem cell transplant recipients on steroids: a 1-year prospective study.

Colombier MA, Lafaurie M, de Fontbrune FS, Resche-Rigon M, Donay JL, Pons JL, Molina JM, Socie G.

Transpl Infect Dis. 2016 Aug;18(4):504-11. doi: 10.1111/tid.12552. Epub 2016 Aug 1.

PMID:
27218243
20.

Necrotizing cellulitis with multiple abscesses on the leg caused by Serratia marcescens.

Hau E, Bouaziz JD, Lafaurie M, Saussine A, Masson V, Rausky J, Bagot M, Guibal F.

Cutis. 2016 Mar;97(3):E8-E12. Review.

PMID:
27023094
21.

Use of Prophylactic Antibiotics in Mechanically Ventilated Patients With Burn Injuries.

Legrand M, Lafaurie M.

Clin Infect Dis. 2016 Jun 1;62(11):1464-5. doi: 10.1093/cid/ciw129. Epub 2016 Mar 6. No abstract available.

PMID:
26951574
22.

Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study.

Denis B, Lafaurie M, Donay JL, Fontaine JP, Oksenhendler E, Raffoux E, Hennequin C, Allez M, Socie G, Maziers N, Porcher R, Molina JM.

Int J Infect Dis. 2015 Oct;39:1-6. doi: 10.1016/j.ijid.2015.07.010. Epub 2015 Jul 17.

23.

Postprescription review improves in-hospital antibiotic use: a multicenter randomized controlled trial.

Lesprit P, de Pontfarcy A, Esposito-Farese M, Ferrand H, Mainardi JL, Lafaurie M, Parize P, Rioux C, Tubach F, Lucet JC.

Clin Microbiol Infect. 2015 Feb;21(2):180.e1-7. doi: 10.1016/j.cmi.2014.08.015. Epub 2014 Oct 14.

24.

Images in clinical medicine. Actinomycetoma.

Viguier M, Lafaurie M.

N Engl J Med. 2015 Jan 15;372(3):264. doi: 10.1056/NEJMicm1316013. No abstract available.

25.

Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study.

Lafaurie M, De Sousa B, Ponscarme D, Lapidus N, Daudon M, Weiss L, Rioux C, Fourn E, Katlama C, Molina JM.

PLoS One. 2014 Nov 19;9(11):e112836. doi: 10.1371/journal.pone.0112836. eCollection 2014.

26.

Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use.

Lepeule R, Leflon-Guibout V, Vanjak D, Zahar JR, Lafaurie M, Besson C, Lefort A; Groupe des Référents en Infectiologie d’Île-de-France (GRIF).

Med Mal Infect. 2014 Dec;44(11-12):530-4. doi: 10.1016/j.medmal.2014.09.004. Epub 2014 Oct 11.

PMID:
25311839
27.

Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.

Lerolle N, Raffoux E, Socie G, Touratier S, Sauvageon H, Porcher R, Bretagne S, Bergeron A, Azoulay E, Molina JM, Lafaurie M.

Clin Microbiol Infect. 2014 Nov;20(11):O952-9. doi: 10.1111/1469-0691.12688. Epub 2014 Jul 12.

28.

Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy.

Sbidian E, Battistella M, Legoff J, Lafaurie M, Bézier M, Agbalika F, Simon F, Bouscarat F, Cayuela JM, Carcelain G, Houhou N, Bagot M, Molina JM, Janier M, Bachelez H.

Clin Infect Dis. 2013 Dec;57(11):1648-55. doi: 10.1093/cid/cit592. Epub 2013 Sep 24.

PMID:
24065320
29.

Linear immunoglobulin-A bullous dermatosis complicating multi-organ tuberculosis at early-stage treatment.

Morice C, Monsel G, Lafaurie M, Battistella M, Manciet JR, Bagot M, Petit A, Viguier M.

Br J Dermatol. 2013 Jul;169(1):210-1. doi: 10.1111/bjd.12286. No abstract available.

PMID:
23448154
30.

Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 132 SMILE].

Lafaurie M, Dolivo M, Girard PM, May T, Bouchaud O, Carbonnel E, Madelaine I, Loze B, Porcher R, Molina JM; ANRS 132 SMILE study group.

HIV Med. 2013 Aug;14(7):410-20. doi: 10.1111/hiv.12021. Epub 2013 Feb 24.

31.

[Reliability and Validity of the Scale for Homophobia in Medicine Students].

Campo-Arias A, Lafaurie MM, Gaitán-Duarte HG.

Rev Colomb Psiquiatr. 2012 Dec;41(4):867-80. doi: 10.1016/S0034-7450(14)60052-4. Epub 2014 May 10. Spanish.

PMID:
26572271
32.

[Quantitative assessment of fungal risk in the case of construction works in healthcare establishments: Proposed indicators for the determination of the impact of management precautions on the risk of fungal infection].

Gangneux JP, Adjidé CC, Bernard L, Botterel F, Carel A, Castel O, Derouin F, Hoarau G, Labussière H, Lafaurie M, Millon L, Pottecher B, Thiebaut A, Turco M, Baron R.

J Mycol Med. 2012 Mar;22(1):64-71. doi: 10.1016/j.mycmed.2012.01.003. Epub 2012 Feb 22. Review. French.

PMID:
23177816
33.

Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.

Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A, Andreoli AL, Rodriguez-Otero P, Dhedin N, Socié G, Ribaud P, Peffault de Latour R.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1295-301. doi: 10.1016/j.bbmt.2012.02.010. Epub 2012 Feb 28.

34.

Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study.

Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM.

J Antimicrob Chemother. 2012 Apr;67(4):1010-5. doi: 10.1093/jac/dkr555. Epub 2012 Jan 11.

PMID:
22240401
35.

[Prescriptions of glycopeptides in 10 university hospitals in Paris area: a 1-day survey].

Lafaurie M, Jaureguy F, Lefort A, Lesprit P, Mainardi JL; Groupe des référents en infectiologie d'Île-de-France (GRIF).

Rev Med Interne. 2011 Mar;32(3):149-53. doi: 10.1016/j.revmed.2010.09.022. Epub 2010 Oct 30. French.

PMID:
21036428
36.

Kaposi's sarcoma after long-acting steroids: time until remission and drug washout.

Nassar D, Schartz NE, Bouché C, Lévy A, Kerob D, Agbalika F, Lafaurie M, Lebbé C.

Dermatology. 2010;220(2):159-63. doi: 10.1159/000277613. Epub 2010 Jan 29. Review.

PMID:
20110636
37.

High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.

Lafaurie M, Lapalu J, Raffoux E, Breton B, Lacroix C, Socié G, Porcher R, Ribaud P, Touratier S, Molina JM.

Clin Microbiol Infect. 2010 Aug;16(8):1191-6. doi: 10.1111/j.1469-0691.2009.03050.x. Epub 2009 Sep 3.

38.

Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells.

Bourgarit A, Carcelain G, Samri A, Parizot C, Lafaurie M, Abgrall S, Delcey V, Vicaut E, Sereni D, Autran B; PARADOX Study Group.

J Immunol. 2009 Sep 15;183(6):3915-23. doi: 10.4049/jimmunol.0804020.

39.

[Fluoroquinolones use at the Saint-Louis Hospital: investigations before and after diffusion of recommendations and interventions of the anti-infectious referent].

Politis B, Pagnon V, Lescot C, Faure P, Touratier S, Lafaurie M.

Pathol Biol (Paris). 2010 Dec;58(6):415-9. doi: 10.1016/j.patbio.2008.11.004. Epub 2009 Feb 5. French.

PMID:
19200663
40.

Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial.

Lafaurie M, Collin F, Bentata M, Garré M, Leport C, Levy Y, Goujard C, Chêne G, Molina JM; ALIZE Study Group.

J Antimicrob Chemother. 2008 Nov;62(5):1122-9. doi: 10.1093/jac/dkn309. Epub 2008 Jul 28.

PMID:
18662943
41.

Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients.

Simonney N, Dewulf G, Herrmann JL, Gutierrez MC, Vicaut E, Boutron C, Leportier M, Lafaurie M, Abgrall S, Sereni D, Autran B, Carcelain G, Bourgarit A, Lagrange PH.

Tuberculosis (Edinb). 2008 Sep;88(5):453-61. doi: 10.1016/j.tube.2008.01.006. Epub 2008 May 21.

PMID:
18495539
42.

[Umbilicated papules of the head, neck and trunk in an HIV-positive patient].

Dauendorffer JN, Levy A, Lagrange-Xélot M, Vignon-Pennamen MD, Lacroix C, Lafaurie M.

Ann Dermatol Venereol. 2008 Apr;135(4):322-4. doi: 10.1016/j.annder.2007.11.024. Epub 2008 Mar 7. French. No abstract available.

PMID:
18420086
43.

[Traceability of a resorbable implant for lipoatrophy: why should it be traced and how should this be done? Example of polylactic acid (Newfill)].

Dupont C, Lafaurie M, Madelaine-Chambrin I, Macaux M, Molina JM, Faure P.

Med Mal Infect. 2007 Dec;37(12):824-7. Epub 2007 Oct 18. French.

PMID:
17949932
44.

Women's perspectives on medical abortion in Mexico, Colombia, Ecuador and Peru: a qualitative study.

Lafaurie MM, Grossman D, Troncoso E, Billings DL, Chávez S.

Reprod Health Matters. 2005 Nov;13(26):75-83.

45.

Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients.

Lafaurie M, Dolivo M, Porcher R, Rudant J, Madelaine I, Molina JM.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):393-8.

PMID:
15764955
46.

Successful treatment of pulmonary mucormycosis in an allogenic bone-marrow transplant recipient with combined medical and surgical therapy.

Pavie J, Lafaurie M, Lacroix C, Marie Zagdanski A, Debrosse D, Socié G, Derouin F, Gluckman E, Michel Molina J.

Scand J Infect Dis. 2004;36(10):767-9.

PMID:
15513407
47.

Evaluation of biomarkers in caged fishes and mussels to assess the quality of waters in a bay of the NW Mediterranean Sea.

Stien X, Percic P, Gnassia-Barelli M, Roméo M, Lafaurie M.

Environ Pollut. 1998;99(3):339-45.

PMID:
15093298
48.

Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults.

Momméja-Marin H, Lafaurie M, Scieux C, Galicier L, Oksenhendler E, Molina JM.

Clin Infect Dis. 2003 Dec 1;37(11):1527-33. Epub 2003 Nov 6.

PMID:
14614676
49.

Aseptic meningitis associated with intravenous administration of dexchlorpheniramine.

Lafaurie M, Dixmier A, Molina JM.

Ann Med Interne (Paris). 2003 May;154(3):179-80.

PMID:
12910046
50.

Human herpesvirus 8-associated hemophagocytic lymphohistiocytosis in human immunodeficiency virus-infected patients.

Fardet L, Blum L, Kerob D, Agbalika F, Galicier L, Dupuy A, Lafaurie M, Meignin V, Morel P, Lebbé C.

Clin Infect Dis. 2003 Jul 15;37(2):285-91. Epub 2003 Jul 1.

PMID:
12856221

Supplemental Content

Loading ...
Support Center